|
1. Tettey J. Recommended Methods for the Identification and Analysis of Cannabis and Cannabis Products. New York: United Nations Office on Drugs and Crime Vienna United Nations. 2009. 2. Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends Pharmacol Sci. 2009 Oct; 30(10): 515-27. doi: 10.1016/j.tips.2009.07.006 3. Hartman RL, Brown TL, Milavetz G, Spurgin A, Gorelick DA, Gaffney G, et al. Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships. Drug Test Anal. 2016 Jul; 8(7): 690-701. doi: 10.1002/dta.1839 4. Borgelt LM, Franson KL, Nussbaum AM, Wang GS. The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy. 2013 Feb; 33(2): 195-209. doi: 10.1002/phar.1187 5. D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, et al. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology. 2004 Aug; 29(8): 1558-72. doi: 10.1038/sj.npp.1300496 6. Kochman LJ, dos Santos AA, Fornal CA, Jacobs BL. Despite strong behavioral disruption, Delta9-tetrahydrocannabinol does not affect cell proliferation in the adult mouse dentate gyrus. Brain Res. 2006 Oct; 1113(1):86-93. doi: 10.1016/j.brainres.2006.07.080 7. Hernán Pérez de la Ossa D, Lorente M, Gil-Alegre ME, Torres S, García-Taboada E, Aberturas Mdel R, et al. Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme. PLoS One. 2013; 8(1): e54795. doi: 10.1371/journal.pone.0054795 8. Aviello G, Romano B, Borrelli F, Capasso R, Gallo L, Piscitelli F, et al. Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer. J Mol Med (Berl). 2012 Aug; 90(8): 925-34. doi: 10.1007/s00109-011-0856-x 9. Fisher T, Golan H, Schiby G, PriChen S, Smoum R, Moshe I, et al. In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma. Curr Oncol. 2016 Mar; 23(2): S15-22. doi: 10.3747/co.23.2893 10. Xie J, Xiao D, Xu Y, Zhao J, Jiang L, Hu X, et al. Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2. Oncotarget. 2016 Feb; 7(6): 6436-47. doi: 10.18632/oncotarget.7042 11. Cakici C, Buyrukcu B, Duruksu G, Haliloglu AH, Aksoy A, Isık A, et al. Recovery of fertility in azoospermia rats after injection of adipose-tissue derived mesenchymal stem cells: The sperm generation. BioMed Research International. Volume 2013, Article ID 529589. http://dx.doi.org/10.1155/2013/529589 12. Bluguermann C,Wu L, Petrigliano F, Mcallister D, Miriuka S, Evseenko DA. Novel aspects of parenchymal–mesenchymal interactions: from cell types to molecules and beyond. Cell Biochemistry and Function. 2013 Jun; 31(4): 271-80. doi: 10.1002/cbf.2950 13. Mehrabani D, Hassanshahi MA, Tamadon A, Zare S, Keshavarz S, Rahmanifar F, et al. Adipose tissue-derived mesenchymal stem cells repair germinal cells of seminiferous tubules of busulfan-induced azoospermic rats. J Hum Reprod Sci. 2015 Apr-Jun; 8(2): 103-10. doi: 10.4103/0974-1208.158618 14. Di Battista JA, Shebaby W, Kizilay O, Hamade E, Abou Merhi R, Mebarek S, et al. Proliferation and differentiation of human adipose-derived mesenchymal stem cells (ASCs) into osteoblastic lineage are passage dependent. Inflamm Res. 2014 Nov; 63(11): 907-17. doi: 10.1007/s00011-014-0764-y 15. Al-Nbaheen M, Vishnubalaji R, Ali D, Bouslimi A, Al-Jassir F, Megges M, et al. Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential. Stem Cell Rev. 2013 Feb; 9(1): 32-43. doi: 10.1007/s12015-012-9365-8 16. Abdanipour A, Noori-Zadeh A, Mohamadi Z, Rashid Sheykh Ahmad F, Akbari P. [Comparison of adipose-derived stem cells and bone marrow stromal cells in prolonged passages based on viability and auto-differentiation]. J Rafsanjan Univ Med Sci. 2015; 13(12): 1141-52. [Article in Persian] 17. Solali S, Kaviani S, Soleimani M, Zonoubi Z. [Isolation and characterization of mesenchymal stem cells derived from adipose tissue]. Koomesh. 2015; 16(4): 505-11. [Article in Persian] 18. de Lago E, Gómez-Ruiz M, Moreno-Martet M, Fernández-Ruiz J. Cannabinoids, multiple sclerosis and neuroprotection. Expert Rev Clin Pharmacol. 2009 Nov; 2(6): 645-60. doi: 10.1586/ecp.09.42 19. Rieder SA, Chauhan A, Singh U, Nagarkatti M, Nagarkatti P. Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. Immunobiology. 2010; 215(8): 598-605. doi: 10.1016/j.imbio.2009.04.001 20. Chakravarti B, Ravi J, Ganju RK. Cannabinoids as therapeutic agents in cancer: current status and future implications. Oncotarget. 2014 Aug; 5(15): 5852-72. 10.18632/oncotarget.2233 21. Bamdadpasand Shekarsarayi F, Eslami Farsani M, Heydariya N. [The effect of soy isoflavone on the proliferation and differentiation of adipose-derived mesenchymal stem cells into chondrocytes and expression of collagen II and aggrecan genes]. Qom Univ Med Sci J. 2017; 11(1): 18-28. [Article in Persian] 22. Milman G, Bergamaschi MM, Lee D, Mendu DR, Barnes AJ, Vandrey R, et al. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence. Ther Drug Monit. 2014 Apr; 36(2): 218-24. doi: 10.1097/FTD.0b013e3182a5c446 23. Berghaus G, Scheer N, Schmidt P. Effects of Cannabis on Psychomotor Skills and Driving Performance - a Metaanalysis of Experimental Studies. 13th International Conference on Alcohol, Drugs and Traffic Safety (T'95). Australia, 13-18 August 1995. 24. Appendino G, Chianese G, Taglialatela-Scafati O. Cannabinoids: occurrence and medicinal chemistry. Curr Med Chem. 2011; 18(7): 1085-99. 25. Khare M, Taylor AH, Konje JC, Bell SC. Delta9-tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription. Mol Hum Reprod. 2006 May; 12(5): 321-33. doi: 10.1093/molehr/gal036 26. Galve-Roperh I, Chiurchiù V, Díaz-Alonso J, Bari M, Guzmán M, Maccarrone M. Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation. Prog Lipid Res. 2013 Oct; 52(4): 633-50. doi: 10.1016/j.plipres.2013.05.004 27. Gowran A, McKayed K, Campbell VA. The cannabinoid receptor type 1 is essential for mesenchymal stem cell survival and differentiation: implications for bone health. Stem Cells Int. 2013; 2013: 796715. doi: 10.1155/2013/796715 28. Prenderville JA, Kelly ÁM, Downer EJ. The role of cannabinoids in adult neurogenesis. Br J Pharmacol. 2015 Aug; 172(16): 3950-63. doi: 10.1111/bph.13186 29. Maccarrone M, Guzmán M, Mackie K, Doherty P, Harkany T. Programming of neural cells by (endo) cannabinoids: from physiological rules to emerging therapies. Nat Rev Neurosci. 2014 Dec; 15(12): 786-801. doi: 10.1038/nrn3846 30. Karsenty G. Convergence between bone and energy homeostases: leptin regulation of bone mass. Cell Metab. 2006 Nov; 4(5): 341-48. doi: 10.1016/j.cmet.2006.10.008 31. Jamshidi M, Hosseini SE, Mehrabani D, Amini M. Effect of hydroalcoholic extract of Cannabis (Cannabis sativa L.) on morphology and the process of human adipose-drived mesenchymal stem cell growth. Electron J Gen Med. 2018; 15(3): em31. doi:10.29333/ejgm/86194
|
